
Jeff Bezos, Chief Executive of Amazon, said the company continues to investigate the allegations behind a Wall Street Journal article in April that detailed how Amazon employees used individual third-party seller data to develop Amazon-branded products, reported the WSJ.
Testifying before the House Antitrust Subcommittee in his first appearance before Congress, Mr. Bezos faced repeated questions from lawmakers in both parties about the story’s findings. He noted that Amazon has a policy prohibiting employees from using data on specific sellers to inform decisions about launching or developing its own products.
“I can’t guarantee you that that policy has never been violated,” Mr. Bezos said, noting that the company was working to better understand some of the anecdotes in the Journal’s coverage. Mr. Bezos emphasized that Amazon wants third-party sellers to succeed.
Amazon has acknowledged that its employees can use and review “aggregate” seller data, when there are multiple sellers of the same product. The Journal investigation detailed examples of supposedly aggregated data being derived exclusively or almost entirely from one seller, according to former Amazon employees and documents reviewed in the investigation.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas